Supernus Pharmaceuticals | SUPN - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q3 Sep/2025 0.59 -0.80 Nov/10
FY2026Q2 Jun/2026 -1.01 0.43 0.40 Aug/03
FY2026Q1 Mar/2026 0.60 0.52 -0.21 May/05
FY2025Q4 Dec/2025 -0.07 0.41 0.27 Feb/24
FY2025Q3 Sep/2025 -0.80 0.37 0.69 Nov/04




Eps Alterar Data
Abbott USD 1.31 0.16 2026-06
ANI Pharmaceuticals USD 2.05 0.28 2026-03
Aurora Cannabis CAD -0.13 0.51 2026-03
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Canopy Growth CAD -0.4 0.35 2026-03
Cara Therapeutics USD -0.72 0.14 2026-03
Corcept Therapeutics USD 0.36 0.66 2026-06
Eisai JPY 64.71 76.24 2026-06
Eli Lilly USD 8.38 0.17 2026-06
Novo Nordisk DKK 4.74 6.17 2026-06
Pacira USD 0.73 0.13 2026-06
Perrigo USD 0.5 0.07 2026-06
Pfizer USD 0.77 0.02 2026-06
Supernus Pharmaceuticals USD -1.01 1.61 2026-06
United Therapeutics USD 7.27 1.45 2026-06
Xeris Pharmaceuticals USD 0.01 0.04 2026-03